SGLT2 versus DPP-4 inhibitors in type 2 diabetes: a meta-analysis of outcomes
Objective To systematically compare sodium-glucose linked transporter 2 inhibitors (SGLT2i) and dipeptidyl peptidase 4 inhibitors (DPP4i) in glycemic control, weight reduction and genital infection risk in type 2 diabetic patients, and provide evidence-based support for individualized clinical medication. Materials and...